Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer--report on clinical outcome and dose to critical organs.

Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer--report on clinical outcome and dose to critical organs.

Item
http://www.wikidata.org/entity/Q40114630
Normal tissue toxicity after small field hypofractionated stereotactic body radiation.Robotic Radiosurgery for Adrenal Gland Metastases.The CyberKnife radiosurgery system for lung cancer.Treating adrenal tumors in 26 patients with CyberKnife: a mono-institutional experienceComparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancerWhat would be the most appropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer.Hypofractionated radiotherapy has the potential for second cancer reduction.Dose differences in intensity-modulated radiotherapy plans calculated with pencil beam and Monte Carlo for lung SBRT.Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy.Dosimetric evaluation of abdominal compression as a method to reduce the incidence of radiation-induced pneumonitis in lung SBRT treatment.A design of a DICOM-RT-based tool box for nonrigid 4D dose calculation.Real-time monitoring and control on deep inspiration breath-hold for lung cancer radiotherapy--combination of ABC and external marker tracking.Lung deformations and radiation-induced regional lung collapse in patients treated with stereotactic body radiation therapy.[Preliminary effect of Cyberknife radiosurgery in the treatment of 31 patients with advanced non-small cell lung cancer].
P2860

Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer--report on clinical outcome and dose to critical organs.

Item
http://www.wikidata.org/entity/Q40114630
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Hypofractionated stereotactic ...... e and dose to critical organs.
@en
type
label
Hypofractionated stereotactic ...... e and dose to critical organs.
@en
prefLabel
Hypofractionated stereotactic ...... e and dose to critical organs.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Hypofractionated stereotactic ...... e and dose to critical organs.
@en
P2093
P304
P31
P356
10.1016/J.RADONC.2008.02.015
P433
P478
P577
P698
P921